- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1616KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 504KB)
Empagliflozin – November 2021
Empagliflozin: Tablet 10 mg; Jardiance®
Last updated
4 March 2022